For: | Gallo P, Terracciani F, Di Pasquale G, Esposito M, Picardi A, Vespasiani-Gentilucci U. Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures. World J Gastroenterol 2022; 28(30): 4061-4074 [PMID: 36157107 DOI: 10.3748/wjg.v28.i30.4061] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i30/4061.htm |
Number | Citing Articles |
1 |
Steven L. Flamm. Key Insights and Clinical Pearls in the Identification and Management of Cirrhosis and Its Complications. The American Journal of Medicine 2024; 137(10): 929 doi: 10.1016/j.amjmed.2024.05.015
|
2 |
Sofía Martínez Jiménez. Cutaneous Manifestations of Liver Disease: A Narrative Review. Cureus 2024; doi: 10.7759/cureus.70357
|
3 |
Ramsha Sohail, Imran H Hassan, Mah Rukh, Muhammad Saqib, Muhammad Iftikhar, Hassan Mumtaz. Assessing Thrombocytopenia and Chronic Liver Disease in Southeast Asia: A Multicentric Cross-Sectional Study. Cureus 2023; doi: 10.7759/cureus.43356
|
4 |
Monalisa Sahu, Dibyalochan Praharaj, Ajeet S. Bhadoria. Vaccination Strategies for a Liver Transplant Recipient. Journal of Clinical and Experimental Hepatology 2025; 15(2): 102421 doi: 10.1016/j.jceh.2024.102421
|
5 |
Lijun Chen, Ning Zhang, Yuqi Huang, Qi Zhang, Yangxin Fang, Jiamin Fu, Yin Yuan, Lu Chen, Xin Chen, Zhenyu Xu, Yifei Li, Hiromi Izawa, Charlie Xiang. Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside. Stem Cell Reviews and Reports 2023; 19(7): 2192 doi: 10.1007/s12015-023-10583-5
|
6 |
Wanxin Shi, Huiwen Yan, Xiaoli Liu, Lihua Yu, Yuqing Xie, Yuan Wu, Yuling Liang, Zhiyun Yang. Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8+T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis. Journal of Hepatocellular Carcinoma 2024; : 1049 doi: 10.2147/JHC.S452688
|
7 |
Kexing Han, Jianfeng Wang, Xizhen Song, Luyang Kang, Junjie Lin, Qinggang Hu, Weijie Sun, Yufeng Gao. Development and validation of a nomogram for predicting advanced liver fibrosis in patients with chronic hepatitis B. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1452841
|
8 |
Ji Li, Ke-Xing Han, Jia-Pei Shen, Wei-Jie Sun, Long Gao, Yu-Feng Gao. Value of XGBoost machine learning model for diagnosis of hepatitis B cirrhosis. World Chinese Journal of Digestology 2023; 31(13): 544 doi: 10.11569/wcjd.v31.i13.544
|
9 |
Maria Y. Nadinskaia, Khava B. Kodzoeva, Kseniya A. Gulyaeva, Mariia-Doris E. Khen, Diana I. Koroleva, Vladimir T. Ivashkin. Causes for the absence of thrombocytopenia in patients with liver cirrhosis and portal vein thrombosis: A case-control study. Almanac of Clinical Medicine 2023; 51(4): 207 doi: 10.18786/2072-0505-2023-51-025
|
10 |
Joseph Anejo-okopi, Oludare Oladipo Agboola, David Ochola Amanyi, Ocheme Julius Okojokwu, Chika Onwuamah, Bulus Jonathan, Chima Anyuku Azubuike, Akpa Samuel Tanko, Seljul Mamzhi Crown Ramyil, Otobo Innocent Ujah. Assessment of liver fibrosis by transient elastography among human immunodeficiency virus/hepatitis B virus and hepatitis B virus-mono-infected patients on tenofovir therapy in Jos, Nigeria. Sri Ramachandra Journal of Health Sciences 2024; 4: 19 doi: 10.25259/SRJHS_32_2023
|
11 |
Paolo Gallo, Antonio De Vincentis, Francesca Terracciani, Andrea Falcomatà, Valeria Pace Palitti, Maurizio Russello, Anthony Vignone, Domenico Alvaro, Raffaella Tortora, Marco Biolato, Maurizio Pompili, Vincenza Calvaruso, Veneziano Marzia, Marco Tizzani, Alessandro Caneglias, Francesco Frigo, Marcantonio Gesualdo, Alfredo Marzano, Valerio Rosato, Ernesto Claar, Rosanna Villani, Antonio Izzi, Raffaele Cozzolongo, Antonio Cozzolino, Aldo Airoldi, Chiara Mazzarelli, Marco Distefano, Claudia Iegri, Stefano Fagiuoli, Vincenzo Messina, Enrico Ragone, Rodolfo Sacco, Pierluigi Cacciatore, Flora Masutti, Saveria Lory Crocé, Alessandra Moretti, Valentina Flagiello, Giulia Di Pasquale, Antonio Picardi, Umberto Vespasiani-Gentilucci. Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study. Journal of Clinical Medicine 2024; 13(13): 3965 doi: 10.3390/jcm13133965
|
12 |
Jae Cheol Jung, Shin-Young Park, Kyeong Deok Kim, Woo Young Shin, Keon-Young Lee. Evolution of splenomegaly in liver cirrhosis: Simulation using an electronic circuit. Advances in Medical Sciences 2024; 69(2): 377 doi: 10.1016/j.advms.2024.08.001
|
13 |
Randi J. Wong, Jin Ge, Justin Boike, Margarita German, Giuseppe Morelli, Erin Spengler, Adnan Said, Archita Desai, Thomas Couri, Sonali Paul, Catherine Frenette, Elizabeth C. Verna, Aparna Goel, Michael Fallon, Bartley Thornburg, Lisa VanWagner, Jennifer C. Lai, K. Pallav Kolli. Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. Journal of Vascular and Interventional Radiology 2023; 34(8): 1364 doi: 10.1016/j.jvir.2023.04.015
|
14 |
Zhong Xue, Maohua Chen, Mingzuo Wang, Fan Zhang, Zhaoshuo Chen. A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-80067-0
|
15 |
Mohammed Haidar Hazaa Al-Dholae, Mohammed Kassim Salah, Omar Yahya Al-Ashmali, Abdul Salam Mohamed Al Mokdad, Mohammed Ali Al-Madwami. Thrombocytopenia (TCP), MELD Score, and Fibrosis Index (FI) Among Hospitalized Patients with Chronic Liver Disease (CLD) in Ma’abar City, Dhamar Governorate, Yemen: A Cross-Sectional Study. Hepatic Medicine: Evidence and Research 2023; : 43 doi: 10.2147/HMER.S392011
|
16 |
Hao Zhang, Kai Yang, Qin Wang, Lei Jin, Ling-Mei Wang, Xing-Yu Fan, Xiu Wang, Qiang Zhou, Yuan-Hong Xu. Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure. Infection and Drug Resistance 2023; : 2611 doi: 10.2147/IDR.S402585
|
17 |
Tagreed A. Mazi, Kimber L. Stanhope. Elevated Erythritol: A Marker of Metabolic Dysregulation or Contributor to the Pathogenesis of Cardiometabolic Disease?. Nutrients 2023; 15(18): 4011 doi: 10.3390/nu15184011
|
18 |
Christos Stafylidis, Dimitra Vlachopoulou, Stavroula Syriopoulou, Sevastianos Chatzidavid, Nora-Athina Viniou. Novel Perspectives on Thrombopoietin Receptor Agonists Applications. Hämostaseologie 2024; doi: 10.1055/a-2250-9369
|
19 |
Ao Huang, Jia-Feng Chen, Jian-Zhang Wu, Zheng Gao, Ying-Hong Shi, Xiu-Tao Fu, Xin Zhang, Wei-Ren Liu, Qiang Gao, Hui-Chuan Sun, Guo-Ming Shi, Jia Fan, Zhen-Bin Ding, Jian Zhou, Shuanglin Qin. Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/9138195
|
20 |
Mohamed Khayata, Richard A. Grimm, Brian P. Griffin, Bo Xu. Prevalence, Characteristics, and Outcomes of Infective Endocarditis Readmissions in Patients With Variables Associated With Liver Disease in the United States. Angiology 2024; doi: 10.1177/00033197241227502
|
21 |
Kasumi Satoh, Takeshi Wada, Akihito Tampo, Gaku Takahashi, Kota Hoshino, Hironori Matsumoto, Takayuki Taira, Satoshi Kazuma, Takamitsu Masuda, Takashi Tagami, Hiroyasu Ishikura, Takayuki Ogura, Yu Kawazoe, Yudai Takatani, Chie Tanaka, Kensuke Nakamura, Yoshihiko Nakamura, Katsunori Mochizuki, Maiko Yamazaki. Practical approach to thrombocytopenia in patients with sepsis: a narrative review. Thrombosis Journal 2024; 22(1) doi: 10.1186/s12959-024-00637-0
|
22 |
Xianglin Yuan. Chinese expert consensus on managing thrombocytopenia in patients with cancer and liver injury. Oncology and Translational Medicine 2023; 9(1): 1 doi: 10.1007/s10330-023-0628-8
|